.

.
.
**
**

Monday, 15 September 2014

Statements of Principles Update

At the meeting of 6 August 2014 the RMA:

Determined Statements of Principles (SoPs) for:
  • peripheral neuropathy..................................................................74/2014 & 75/2014
  • Creutzfeldt-Jakob disease............................................................76/2014 & 77/2014
  • vascular dementia.......................................................................78/2014 & 79/2014
  • malignant neoplasm of unknown primary site.................................80/2014 & 81/2014
  • posttraumatic stress disorder.......................................................82/2014 & 83/2014
  • chronic lymphocytic leukaemia/small lymphocytic lymphoma........84/2014 & 85/2014
These SoPs revoke the SoPs previously determined for these conditions.

Determined Amendment SoPs for:
  • non-Hodgkin’s lymphoma.............................................................86/2014 & 87/2014
  • diabetes mellitus.........................................................................88/2014 & 89/2014
The above determinations conclude the previously advertised investigations into:
  • peripheral neuropathy
  • Creutzfeldt-Jakob disease
  • vascular dementia
  • malignant neoplasm of unknown primary site
  • posttraumatic stress disorder
  • chronic lymphoid leukaemia [now known as – chronic lymphocytic leukaemia/small lymphocytic lymphoma]
  • non-Hodgkin's lymphoma
  • diabetes mellitus
 The above SoPs take effect from 22 September 2014.

Download the 'Summary of Changes' regarding SoPs 74 – 89/2014     (pdf – 711KB)  


Decided to advertise the following investigation:
  • neoplasm of the pituitary gland
The Investigation Notice for this investigation will appear in the Government Notices Gazette of 19 September 2014.